Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Pharmaceutical Sovereignty as HIV Justice: Colombia's Dolutegravir License and the Future of ART Access in Latin America
Saved in:
| Published in: | Journal of the International AIDS Society |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmaceutical Sovereignty as HIV Justice: Colombia's Dolutegravir License and the Future of ART Access in Latin America
- Latin America and the Caribbean: Challenges and Opportunities for HIV Treatment and Prevention
- Latin America and the Caribbean: Socioeconomic Realities and Implications for Health and HIV Responses
- Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIV
- Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry
- Aesthetic Use of Poly-L-Lactic Acid and Hyaluronic Acid Fillers in Medication-Driven Weight Loss Due to GLP-1 Receptor Agonists: Real-World Case Series from Latin America
- Longitudinal Weight Gain Trajectories After Initiation of Dolutegravir-Based Antiretroviral Therapy: A Retrospective Cohort Study